ARIDIS PHARMACEUTICALS INC's ticker is ARDS and the CUSIP is 040334104. A total of 1 filers reported holding ARIDIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $320 | -24.9% | 1,459 | +7.8% | 0.00% | – |
| Q1 2023 | $426 | -73.8% | 1,354 | -1.7% | 0.00% | – |
| Q4 2022 | $1,627 | +62.7% | 1,378 | +3.5% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 1,331 | +1.4% | 0.00% | – |
| Q2 2022 | $1,000 | -66.7% | 1,313 | +2.3% | 0.00% | – |
| Q1 2022 | $3,000 | 0.0% | 1,283 | -0.9% | 0.00% | – |
| Q4 2021 | $3,000 | -25.0% | 1,294 | +1.8% | 0.00% | – |
| Q3 2021 | $4,000 | -55.6% | 1,271 | 0.0% | 0.00% | – |
| Q2 2021 | $9,000 | +28.6% | 1,271 | +0.4% | 0.00% | – |
| Q1 2021 | $7,000 | +250.0% | 1,266 | +271.3% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 341 | +2.7% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 332 | -1.8% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 338 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | +100.0% | 338 | +12.7% | 0.00% | – |
| Q4 2019 | $1,000 | -50.0% | 300 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | -33.3% | 300 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -25.0% | 300 | 0.0% | 0.00% | – |
| Q3 2018 | $4,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wealth Architects, LLC | 14,077 | $1,437 | 0.00% |